Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1997-9-22
|
| pubmed:abstractText |
Left ventricular hypertrophy (LVH) is associated with multiple cellular electrophysiological abnormalities, susceptibility to ventricular arrhythmias, and an increased risk of sudden death. Several pharmacological therapies have been shown to produce regression of hypertrophy, but the value of regression is unclear. The present study examines whether pharmacological regression of LVH has effects on the susceptibility to ventricular arrhythmia or the cellular electrophysiological abnormalities of LVH.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0009-7322
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
19
|
| pubmed:volume |
96
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1330-6
|
| pubmed:dateRevised |
2003-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:9286966-Action Potentials,
pubmed-meshheading:9286966-Animals,
pubmed-meshheading:9286966-Captopril,
pubmed-meshheading:9286966-Disease Models, Animal,
pubmed-meshheading:9286966-Electrophysiology,
pubmed-meshheading:9286966-Hypertrophy, Left Ventricular,
pubmed-meshheading:9286966-Rabbits,
pubmed-meshheading:9286966-Ventricular Fibrillation
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation.
|
| pubmed:affiliation |
Cardiovascular Division, The Lankenau Hospital and Medical Research Center, Wynnewood, Pa 19096, USA.
|
| pubmed:publicationType |
Journal Article
|